Nosocomial Respiratory Infections in a Rural Zambian Hospital

Am J Trop Med Hyg. 2021 Jul 19;105(3):818-821. doi: 10.4269/ajtmh.20-1470.

Abstract

The burden of nosocomial respiratory infections in rural southern Africa is poorly understood. We established a surveillance program at a rural Zambian hospital to detect influenza-like illness (ILI) and respiratory infections among hospitalized patients and a cohort of healthcare workers (HCWs). Nasopharyngeal specimens from symptomatic patients and HCWs underwent broadly multiplexed molecular testing to detect viruses and atypical bacteria. During 1 year of surveillance, 15 patients (1.7% of admissions) developed ILI more than 48 hours after admission. Among 44 HCWs, 19 (43%) experienced at least one ILI episode, with a total of 31 ILI episodes detected. Respiratory viruses were detected in 45% of patient and 55% of HCW specimens. The cumulative incidence of influenza infection among HCWs over 1 year was 9%. Overall, respiratory viruses were commonly found among patients and HCWs in a rural Zambian hospital with limited infection control infrastructure.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Child
  • Child, Preschool
  • Cohort Studies
  • Cross Infection / epidemiology*
  • Cross Infection / transmission
  • Cross Infection / virology
  • Female
  • Health Personnel / statistics & numerical data*
  • Hospitals, Rural*
  • Humans
  • Infection Control
  • Infectious Disease Transmission, Professional-to-Patient / statistics & numerical data
  • Influenza Vaccines / therapeutic use
  • Influenza, Human / epidemiology*
  • Influenza, Human / prevention & control
  • Influenza, Human / transmission
  • Male
  • Patients' Rooms
  • Picornaviridae Infections / epidemiology*
  • Picornaviridae Infections / transmission
  • Prospective Studies
  • Respiratory Tract Infections / epidemiology*
  • Respiratory Tract Infections / transmission
  • Respiratory Tract Infections / virology
  • Rhinovirus
  • Zambia / epidemiology

Substances

  • Influenza Vaccines